Home Cart 0 Sign in  

[ CAS No. 53562-51-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 53562-51-9
Chemical Structure| 53562-51-9
Structure of 53562-51-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 53562-51-9 ]

Related Doc. of [ 53562-51-9 ]

Alternatived Products of [ 53562-51-9 ]

Product Details of [ 53562-51-9 ]

CAS No. :53562-51-9 MDL No. :MFCD12026360
Formula : C7H8O2S Boiling Point : -
Linear Structure Formula :- InChI Key :CCNDEWOBDKZGAD-UHFFFAOYSA-N
M.W : 156.20 Pubchem ID :13133923
Synonyms :

Calculated chemistry of [ 53562-51-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.29
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 40.56
TPSA : 54.54 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.93 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.22
Log Po/w (XLOGP3) : 1.86
Log Po/w (WLOGP) : 1.84
Log Po/w (MLOGP) : 1.25
Log Po/w (SILICOS-IT) : 2.79
Consensus Log Po/w : 1.99

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.22
Solubility : 0.945 mg/ml ; 0.00605 mol/l
Class : Soluble
Log S (Ali) : -2.63
Solubility : 0.369 mg/ml ; 0.00236 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.12
Solubility : 1.2 mg/ml ; 0.00766 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.3

Safety of [ 53562-51-9 ]

Signal Word:Warning Class:
Precautionary Statements:P264-P270-P301+P312-P330 UN#:
Hazard Statements:H302 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 53562-51-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 53562-51-9 ]
  • Downstream synthetic route of [ 53562-51-9 ]

[ 53562-51-9 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 67-56-1 ]
  • [ 1918-78-1 ]
  • [ 53562-51-9 ]
YieldReaction ConditionsOperation in experiment
96% for 3 h; Reflux Thionyl chloride (200mL, 2.76mol) was slowly added dropwise to a solution of 9 (100g, 703mmol) in MeOH (500mL). After stirring at reflux for 3h, the mixture was concentrated under reduced pressure. The residue was diluted with CH2Cl2, washed with water, saturated aqueous NaHCO3 and brine, and dried over Na2SO4. After filtration, the solvent was concentrated under reduced pressure to give 105g (96percent) of 10 as a brown oil: 1H NMR (400MHz, CDCl3) δ 7.38 (d, J=5.4Hz, 1H), 6.98 (d, J=5.4Hz, 1H), 3.85 (s, 3H), 2.74 (s, 3H); MS (ESI) m/z: 157 (M+H)+.
78% at 0℃; for 4 h; Reflux 2 (14.00 g, 98.60 mmol) was dissolved inmethanol (60 ml). Concentrated sulfuric acid (30 ml) was added dropwise at 0°C. The reaction mixture was stirred for 4 h at reflux, thenwas cooled to room temperature, and the solvent was evaporated under reducedpressure. The residue was partitioned between CH2Cl2 (200 ml)and H2O (60 ml). The organic phase was washed with H2O (50 ml), saturated aqueous sodium bicarbonate solution (50ml) and saturated brine solution (50 ml),dried over Na2SO4, and filtrated, then the solvent wasevaporated under reduced pressure to give 3 (12.00 g, 78.0percent) as acolorless viscous oil. 1H NMR (400 MHz,CDCl3)δ 7.38 (d, J =5.5 Hz, 1H), 6.98 (d, J = 5.1, 1H), 3.85 (s, 3H), 2.73(s, 3H). MS (EI)m/z: 156 (M+).
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 156, p. 269 - 294
[2] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 18, p. 5417 - 5422
[3] European Journal of Medicinal Chemistry, 2015, vol. 102, p. 471 - 476
[4] Journal of Medicinal Chemistry, 1995, vol. 38, # 24, p. 4806 - 4820
[5] Patent: US2012/101137, 2012, A1, . Location in patent: Page/Page column 14
  • 2
  • [ 40018-26-6 ]
  • [ 1830-54-2 ]
  • [ 865187-80-0 ]
  • [ 53562-51-9 ]
YieldReaction ConditionsOperation in experiment
51% With lithium bromide In 1,4-dioxane for 20 h; Reflux A solution of dimethyl acetone-1,3-dicarboxylate (7) (51.4 g, 0.296 mol) in 1,4-dioxane (75 mL) and then LiBr (28.2 g, 0.325 mol) were added to a stirred suspension of 2,5-dihydroxy-1,4-dithiane (30.0 g, 0.197 mol) in 1,4-dioxane (300 mL). The mixture was stirred at reflux for 20 h. The mixture was filtered into a separating funnel and extracted with ethyl acetate (500 mL) and water (70 mL). The water layer was re-extracted with ethyl acetate (2.x.250 mL) and the combined organic layers were washed with aq HCl (500 mL, 1 M), aq NaHCO3 (5percent), aq NaOH (500 mL, percent10) and then with brine (500 mL). The solution was dried over MgSO4 and the solvent was evaporated. The crude product was purified by column chromatography (350 g) eluting with hexane/ethyl acetate (7:2) and then (5:2) to give monoester 10 as the first fraction. The desired diester 9 was isolated as the second fraction.
Reference: [1] Tetrahedron, 2011, vol. 67, # 45, p. 8679 - 8684
  • 3
  • [ 1918-78-1 ]
  • [ 74-88-4 ]
  • [ 53562-51-9 ]
Reference: [1] Patent: US5475022, 1995, A,
  • 4
  • [ 1918-78-1 ]
  • [ 74-88-4 ]
  • [ 53562-51-9 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1983, vol. 20, # 4, p. 1085 - 1087
  • 5
  • [ 88-13-1 ]
  • [ 53562-51-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 18, p. 5417 - 5422
[2] Patent: US2012/101137, 2012, A1,
[3] European Journal of Medicinal Chemistry, 2015, vol. 102, p. 471 - 476
[4] European Journal of Medicinal Chemistry, 2018, vol. 156, p. 269 - 294
  • 6
  • [ 53562-51-9 ]
  • [ 172292-52-3 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 24, p. 4806 - 4820
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 53562-51-9 ]

Esters

Chemical Structure| 19432-66-7

[ 19432-66-7 ]

Ethyl 2-methylthiophene-3-carboxylate

Similarity: 0.96

Chemical Structure| 67808-70-2

[ 67808-70-2 ]

Ethyl 2-formylthiophene-3-carboxylate

Similarity: 0.92

Chemical Structure| 115777-72-5

[ 115777-72-5 ]

2-(Methoxycarbonyl)thiophene-3-carboxylic acid

Similarity: 0.85

Chemical Structure| 1259396-11-6

[ 1259396-11-6 ]

Methyl 5-bromo-2-methylthiophene-3-carboxylate

Similarity: 0.81

Chemical Structure| 22913-26-4

[ 22913-26-4 ]

Methyl thiophene-3-carboxylate

Similarity: 0.80